StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC – Free Report) from a hold rating to a buy rating in a report issued on Saturday morning.
PAHC has been the topic of a number of other research reports. Morgan Stanley lifted their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Barclays lifted their target price on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research report on Monday, February 10th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, Phibro Animal Health presently has an average rating of “Hold” and a consensus price target of $21.00.
Check Out Our Latest Research Report on Phibro Animal Health
Phibro Animal Health Stock Performance
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Equities analysts expect that Phibro Animal Health will post 1.95 EPS for the current fiscal year.
Phibro Animal Health Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s payout ratio is currently 100.00%.
Hedge Funds Weigh In On Phibro Animal Health
A number of hedge funds and other institutional investors have recently bought and sold shares of PAHC. Millennium Management LLC grew its holdings in Phibro Animal Health by 233.0% during the fourth quarter. Millennium Management LLC now owns 207,749 shares of the company’s stock worth $4,363,000 after purchasing an additional 145,359 shares during the period. Jacobs Levy Equity Management Inc. grew its holdings in Phibro Animal Health by 56.7% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company’s stock worth $6,325,000 after purchasing an additional 108,918 shares during the period. Hussman Strategic Advisors Inc. bought a new stake in shares of Phibro Animal Health during the fourth quarter worth approximately $2,205,000. Nuveen Asset Management LLC boosted its holdings in shares of Phibro Animal Health by 21.4% during the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock worth $12,348,000 after acquiring an additional 103,618 shares during the period. Finally, Alliancebernstein L.P. boosted its holdings in shares of Phibro Animal Health by 357.1% during the fourth quarter. Alliancebernstein L.P. now owns 130,000 shares of the company’s stock worth $2,730,000 after acquiring an additional 101,560 shares during the period. Institutional investors own 99.34% of the company’s stock.
About Phibro Animal Health
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
See Also
- Five stocks we like better than Phibro Animal Health
- Differences Between Momentum Investing and Long Term Investing
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What is a Dividend King?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Trading Halts Explained
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.